ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (The RAPID GENE Study).

Trial Profile

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (The RAPID GENE Study).

Completed
Phase of Trial: Phase II/III

Latest Information Update: 03 Apr 2012

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes; Coronary artery disease; Coronary stent thrombosis
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms RAPID-GENE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Apr 2012 Results published in the Lancet.
    • 22 Aug 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top